RACHAEL PAUVLINCH: Open Payments
NPI 1184137630 · CRANBERRY TWP, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,155 in 116 payments from 31 companies in 2025. Trend: 2023 $2,085 · 2024 $1,791 · 2025 $2,155
Food & beverage: $2,155
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $386 |
| Novo Nordisk Inc | 12 | $229 |
| AstraZeneca Pharmaceuticals LP | 8 | $196 |
| PFIZER INC. | 10 | $153 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $108 |
| Amgen Inc. | 5 | $97 |
| SHIELD THERAPEUTICS INC | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Lilly USA, LLC | 4 | $75 |
Products named: UBRELVY, Auvelity, Wegovy, JARDIANCE, QULIPTA, VRAYLAR, BREZTRI, ACCRUFER.
Industry payments across PA — which companies pay providers there.
